ArticleFrontiers in pharmacology2026
HYAL3 as a therapeutic target for pulmonary arterial Hypertension-Cardiomyopathy comorbidity: an integrative analysis combined with machine learning and SHAP value interpretation.
Jianchuan Hu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.